125I Intracavitary Irradiation Combined with 125I Seeds Implantation for Treatment of Locally Advanced Pancreatic Head Cancer: A Retrospective Analysis of 67 Cases
Shuai Zhou,Chao Zhu,Shi Lei Chen,Jin Ang Li,Kang Lin Qu,Hao Jing,Yong Wang,Qing Pang,Hui Chun Liu
DOI: https://doi.org/10.2147/IJGM.S309069
IF: 2.145
2021-06-18
International Journal of General Medicine
Abstract:Shuai Zhou, Chao Zhu, Shi Lei Chen, Jin Ang Li, Kang Lin Qu, Hao Jing, Yong Wang, Qing Pang, Hui Chun Liu Department of Hepatobiliary Pancreatic Surgery, Hepatobiliary Pancreatic Surgery, The First Affiliated Hospital of Bengbu Medical College, Anhui, 233000, People's Republic of China Correspondence: Hui Chun Liu; Qing Pang Department of Hepatobiliary Pancreatic Surgery, Hepatobiliary Pancreatic Surgery, The First Affiliated Hospital of Bengbu Medical College, Anhui, 233000, People's Republic of China Email ; Background: Pancreatic cancer is an aggressive malignant tumor of the digestive system and the fourth leading cause of tumor-related death. Intracavitary 125 I seed irradiation has been recently developed as a therapy for locally advanced pancreatic head carcinoma. However, there are still many limitations, and more investigations are needed in order to optimize this new treatment method. Methods: Sixty-seven patients were included in our study; 41 cases treated by SEMS-CL- 125 I intracavular irradiation (SEMS-CL- 125 I group) and 26 cases treated by SEMS-CL- 125 I intracavular irradiation combined with 125 I particle implantation in the tumor body (the combined group). Among the 67 patients, 43 were males and 24 were females, with an average age of 69.64± 8.84 years. Tumor site size was determined based on the MRI or CT imaging scans, and the number and radius of 125 I particle placement were calculated according to a specific formula. 125 I particles were inserted into the tumor with a radius of 1.5 cm and a row spacing of 1 cm. The main postoperative biochemical indexes, imaging analysis, postoperative analgesia degree, median survival time and rate of complications were compared between the two groups. Results: Jaundice and liver function improved in both groups after treatment for 6 months. The combined group did better. Kaplan–Meier analysis showed that patients in the combined group had a significantly better overall survival than those in the SEMS-CL- 125 I group. Patients in the combined group had less complications than those in the SEMS-CL- 125 I group (23.1% vs 34.1%), and the postoperative pain status of the combined group was improved (26.8% vs 53.8%). Conclusion: Compared with the SEMS-CL- 125 I intracavular irradiation alone, the combination of 125 I seed implantation with solid tumor 125 I seed implantation had a better therapeutic effect in LAPHC patients, with improved biochemical indicators, survival prognosis, pain relief, and fewer complications. Keywords: locally advanced pancreatic cancer, 125 I, metal biliary stent Pancreatic cancer is an aggressive malignant tumor of the digestive system for which very limited therapeutic options exist. It is the fourth leading cause of cancer death and the 5-year survival rate of patients with pancreatic cancer is about 10%. 1 , 2 Patients with early stage of pancreatic cancer show no obvious clinical symptoms, and in the majority of cases, the disease has progressed to an advanced stage at the time of presentation. 3 About 40% of the patients with pancreatic cancer are diagnosed with locally advanced pancreatic head cancer (LAPHC). LAPHC is defined as pancreatic cancer with extensive local invasion, severe vascular invasion, and no distant metastasis. 4 The opportunity for radical excision is often missed in these patients. In patients with pancreatic cancer who cannot be treated surgically, biliary stents can significantly relieve symptoms and improve their quality of life. 5 However, stent implantation alone does not seem to significantly improve stent patency time and patient survival. 6 125 I seeds have been shown to be effective in killing tumor cells without causing significant damage to the surrounding normal tissues. 7 125 I seeds and postoperatively chemotherapy treatment in locally advanced pancreatic cancer has a better effect than chemotherapy alone . Patient complications and the OS life cycle increased. 8 In comparison with the traditional surgery group, the effect of 125 I implantation in the treatment of advanced local malignant pancreatic cancer is feasible. 9 Biliary stent implantation alone for the treatment of LAPHC still has many limitations, since the rapid progression of the tumor can easily result in biliary obstruction again. 10 SEMS-CL- 125 I has been used to treat LAPHC in m -Abstract Truncated-
medicine, general & internal